Answer questions and earn CME/CNE Oral cavity squamous cell carcinoma (OC‐SCC) is
the most common malignancy of the head and neck (excluding nonmelanoma skin cancer) …

Disclaimer This article is based on recommendations from the 12th WALT Congress, Nice,
October 3-6, 2018, and a follow-up review of the existing data and the clinical observations …

Radiotherapy (RT) is used to treat approximately 80% of patients with cancer of the head
and neck. Despite enormous advances in RT planning and delivery, a significant number of …

Background Patients with HPV+ oropharyngeal squamous cell carcinoma were assigned to
dose and volume de-escalated radiotherapy (RT) or chemoradiotherapy (CRT) based on …

Purpose There is a large body of evidence supporting the efficacy of low-level laser therapy
(LLLT), more recently termed photobiomodulation (PBM) for the management of oral …

Background Owing to its physical properties, intensity-modulated proton therapy (IMPT)
used for patients with oropharyngeal carcinoma has the ability to reduce the dose to organs …

BACKGROUND The National Cancer Institute's Common Terminology Criteria for Adverse
Events (CTCAE) is the universal framework for toxicity reporting in oncology trials. The …

These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for
Head and Neck (H&N) Cancers. These Insights describe the different types of particle …

Objectives/Hypothesis To demonstrate the comparative effectiveness of transoral robotic
surgery (TORS) to intensity modulated radiotherapy (IMRT) for early T‐stage oropharyngeal …

Summarize functional outcomes after transoral robotic surgery (TORS)±adjuvant therapy for
oropharyngeal cancer (OPC). A systematic review was conducted. The MEDLINE database …